Results 21 to 30 of about 1,329,719 (361)
Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021
Diagnostics, 2021 Cardiac amyloidosis is caused by the deposition of misfolded protein fibrils into the extracellular space of the heart. The diagnosis of cardiac amyloidosis remains challenging because of the heterogeneous manifestations of the disease.
Weijia Li +6 more
doaj +1 more source
Clinical Medicine, 2005 Systemic amyloidosis commonly affects the heart. Indeed, cardiac symptoms may be the first clinical indicator of underlying amyloid deposition. Using two case studies, this article reviews the latest evidence regarding cardiac amyloidosis. The diagnosis of cardiac involvement can be established through imaging with echocardiography and magnetic ...
Maredia, Neil, Ray, Simon G
openaire +2 more sources
Echo Research and Practice, 2023 These guidelines form an update of the BSE guideline protocol for the assessment of restrictive cardiomyopathy (Knight et al. in Echo Res Prac, 2013). Since the original recommendations were conceived in 2013, there has been an exponential rise in the ...
W. Moody +13 more
semanticscholar +1 more source
Journal of Clinical Medicine, 2023 Amyloidosis is a systemic disease characterized by extracellular deposits of insoluble amyloid in various tissues and organs. Cardiac amyloidosis is a frequent feature of the disease, causing a progressive, restrictive type of cardiomyopathy, and is ...
N. Laptseva +6 more
semanticscholar +1 more source
Cardiac amyloidosis: state-of-the-art review.
Journal of Geriatric Cardiology, 2023 Cardiac amyloidosis (CA) is caused by deposition of amyloid fibrils in the myocardium and has two main subtypes, transthyretin cardiac amyloidosis (ATTR) and immunoglobulin light chain cardiac amyloidosis (AL).
Syed Bukhari
semanticscholar +1 more source
Role of cardiac MRI in the diagnosis of cardiac amyloidosis. Clinical cases
Клинический разбор в общей медицине, 2021 Purpose. The aim of this work is to show the capabilities of late gadolinium enhancement cardiac magnetic resonance imaging (MRI) in the diagnosis of a rare disease such as cardiac amyloidosis. Materials and methods.
Ekaterina A. Butorova +1 more
doaj +1 more source
Molecular Imaging of Systemic and Cardiac Amyloidosis: Recent Advances and Focus on the Future.
Journal of Nuclear Medicine, 2023 Myocardial infiltration by amyloid fibrils causes a severe and progressive form of heart failure. Until recently, this was not treatable. Several novel therapies have recently become available, increasing the urgency to make an accurate diagnosis ...
S. Dorbala, M. Kijewski
semanticscholar +1 more source
Machine Learning Approaches in Diagnosis, Prognosis and Treatment Selection of Cardiac Amyloidosis
International Journal of Molecular Sciences, 2023 Cardiac amyloidosis is an uncommon restrictive cardiomyopathy featuring an unregulated amyloid protein deposition that impairs organic function. Early cardiac amyloidosis diagnosis is generally delayed by indistinguishable clinical findings of more ...
A. Allegra +5 more
semanticscholar +1 more source
Advance of echocardiography in cardiac amyloidosis
Heart Failure Reviews, 2023 Cardiac amyloidosis (CA) occurs when the insoluble fibrils formed by misfolded precursor proteins deposit in cardiac tissues. The early clinical manifestations of CA are not evident, but it is easy to progress to refractory heart failure with an inferior
Shichu Liang +4 more
semanticscholar +1 more source
Blood-based microRNA profiling in patients with cardiac amyloidosis. [PDF]
PLoS ONE, 2018 INTRODUCTION:Amyloidosis is caused by dysregulation of protein folding resulting in systemic or organ specific amyloid aggregation. When affecting the heart, amyloidosis can cause severe heart failure, which is associated with a high morbidity and ...
Anselm A Derda +8 more
doaj +1 more source